SameerBansilalMD, MS, FACC

Non-Invasive Cardiology, Preventive Cardiology

Attending Physician, James J. Peters Department of Veterans Affairs Medical Center

Dr. Bansilal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2007 - 2011
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2002 - 2005
Seth G.S. Medical CollegeClass of 2001

PubMed

178 citations
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
Sameer Bansilal, José M. Castellano, Ester Garrido, Henry G. Wei, Allison Freeman
Journal of the American College of Cardiology. 2016-08-23
1235 citations
Strategies for Multivessel Revascularization in Patients with Diabetes
Michael E. Farkouh, Michael J. Domanski, Lynn A. Sleeper, Flora S. Siami, George Dangas
The New England Journal of Medicine. 2012-12-19
10 citations
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: a systematic review.
Elio Gorga, Valentina Regazzoni, Sameer Bansilal, Valentina Carubelli, Eleftheria Trichaki
Journal of Cardiovascular Medicine. 2016-08-01

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients with Multivessel Coronary DiseaseJanuary 2018

Bayer’s KERENDIA® (Finerenone) Receives Updated Label to Include Findings from Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients with Chronic Kidney Disease and Type 2 DiabetesSeptember 1st, 2022
Bayer’s KERENDIA® (Finerenone) Receives New Recommendations from American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients with Chronic Kidney Disease Associated with Type 2 DiabetesJune 28th, 2022
Bayer Doles Out $1M of Its PHAB Awards to 7 Research ProjectsSeptember 13th, 2021
Join now to see all